{"id":39979,"date":"2024-02-25T10:54:16","date_gmt":"2024-02-25T10:54:16","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmjgh\/?p=39979"},"modified":"2024-02-25T10:55:33","modified_gmt":"2024-02-25T10:55:33","slug":"addressing-barriers-to-cervical-cancer-prevention-in-the-philippines","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/","title":{"rendered":"Addressing barriers to cervical cancer prevention in the Philippines"},"content":{"rendered":"<h6><\/h6>\n<p>\u2018&#8217;Prevention is better than cure\u201d \u2013 this adage has been around for centuries, and remains to be a fundamental principle of modern medicine. As we celebrate world cancer prevention awareness month this February, we focus on cervical cancer, which has become one of the most preventable malignancies, thanks to effective primary and secondary prevention strategies.<\/p>\n<p>Globally, cervical cancer incidence has reduced mainly due to primary prevention with Human papillomavirus (HPV) vaccination and improved secondary prevention through national screening programs for early detection. However, a huge disparity in the mortality rates remains among countries worldwide, with about <a href=\"https:\/\/www.who.int\/health-topics\/cervical-cancer\">90%<\/a> of cervical cancer deaths occurring in low- and middle-income countries (LMIC). In the Philippines, it is the <a href=\"https:\/\/www.thelancet.com\/journals\/langlo\/article\/PIIS2214-109X(19)30482-6\/fulltext\">second most common cancer <\/a>among women, and survival rates remain low, since <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2676501\/\">75%<\/a> of patients are diagnosed at advanced stages. The high mortality of cervical cancer patients reflects the poor accessibility of health care within the country.<\/p>\n<h6><strong>Early detection is key to prevention<\/strong><\/h6>\n<p>Cervical cytology, commonly known as Pap smear, is the gold standard for cervical cancer screening. However, lack of resources hinder its use in the majority of LMICs, including the Philippines which still utilizes the cheaper alternative of visual inspection with acetic acid (VIA) as the usual primary screening test. Despite this compromise, still only <a href=\"https:\/\/www.iccp-portal.org\/who-cervical-cancer-profile-philippines-2021\">1%<\/a> of women aged 30 &#8211; 49 years in the country have been screened. Financial constraints, poor knowledge on screening, fatalistic attitudes towards cancer, stigma associated with cancer, fear of pain or discomfort and embarrassment during the procedure\u00a0 contribute to <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2211335522002431?via%3Dihub\">low cervical cancer screening uptake<\/a> within the country.<\/p>\n<h6><strong>Better to protect than to regret<\/strong><\/h6>\n<p>Aside from the staggeringly low screening rate, the Philippines also suffers from inadequate HPV vaccination rates. HPV vaccination could prevent more than 90% of malignancies caused by HPV, including cervical cancer. Hence, the World Health Organization (WHO) advocates its introduction in national immunization schedules worldwide by the year 2030.\u00a0 However, <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10227716\/\">vaccination adoption rates remain low in LMICs<\/a> compared to high income countries, despite accounting for most of the global disease burden.<\/p>\n<p>In the Philippines, a school-based HPV vaccination program for girls aged 9\u201314 was started in 2016. However, the scale of the program remains subnational, with only 60% of provinces covered. The country still <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9251542\/\">ranks last<\/a> on HPV program coverage among LMICs, with only 23% of the target population receiving their first, and\u00a0 5% completing their final doses \u2013 a number far from the <a href=\"https:\/\/www.iccp-portal.org\/who-cervical-cancer-profile-philippines-2021\">WHO goal<\/a> to vaccinate 90% of girls by the age of 15.<\/p>\n<p>Identification of eligible individuals is crucial in the successful implementation of any vaccination program. School-based strategies could be beneficial in countries with high school attendance. However, its coverage can be severely limited in countries like the Philippines, where nearly <a href=\"https:\/\/mb.com.ph\/2023\/9\/25\/psa-nearly-20-of-filipino-children-not-in-school\">20%<\/a> of children are out of school, hence missing a significant proportion of the target population. Extending the program to the community-level to include out-of-school youth could hence be useful, in order to achieve higher target population coverage.<\/p>\n<p>It is also essential to emphasize and reinforce timely vaccination of girls before they are sexually active. To further strengthen current evidence on how effective timely administration of HPV vaccines truly is, a recent groundbreaking <a href=\"https:\/\/academic.oup.com\/jnci\/advance-article-abstract\/doi\/10.1093\/jnci\/djad263\/7577291?redirectedFrom=fulltext\">study<\/a> in Scotland has shown that no new cases of invasive cervical cancer were detected in all women born between 1988-1996 nationwide who received HPV vaccinations between the ages of 12 and 13.<\/p>\n<h6><strong>A jab at success for a cervical-cancer free future<\/strong><\/h6>\n<p>GAVI, The Vaccine Alliance (GAVI) was set up as a Global Health Partnership with the goal of creating equal access to new and underused vaccines for children living in most impoverished countries. In particular, Gavi aims to accelerate access to vaccines and strengthen countries\u2019 health and immunization systems. The Philippines, despite classification as an LMIC, was <a href=\"https:\/\/msfaccess.org\/sites\/default\/files\/2022-04\/Philippines_vaccine-case-study_MSF-AC.pdf\">ineligible<\/a> for HPV vaccine financial support. The country had to work with UNICEF, the agency procuring vaccines from manufacturers on behalf of Gavi, to purchase US-based Merck\u2019s quadrivalent vaccine Gardasil at approximately 14 USD per dose. Although\u00a0 lower than the private market price of 160 USD per dose, it was still three times more than the Gavi lowest global price of 4.50 USD per dose. It is therefore not surprising that socioeconomic disparities act as roadblocks to the nation&#8217;s vital preventive programs against HPV infection and cervical cancer.<\/p>\n<p>Recently a new <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1470204523004801\">study<\/a> found the quadrivalent HPV vaccine Cervavac, manufactured by Serum Institute of India (SSI), to be as safe and immunogenic as Gardasil. This new cheaper vaccine could play a pivotal role in meeting the global need for HPV vaccinations and improve coverage worldwide. Furthermore, once Cervavac is made available, it is hoped that the even more affordable pricing could also be extended to the Philippines, considering the burden of cervical cancer within the country. This would allow the Philippines to optimize its financial resources, focus more on preventive care, and become one step closer towards reaching its ultimate goal of cervical cancer reduction within the nation.<\/p>\n<h6><\/h6>\n<h6><strong>About the Authors:<\/strong><\/h6>\n<p>Dr. Janine Audrei T. Pajimna is an internist based in the Philippines.<\/p>\n<p>Dr. Giannina Alyana L. Orpilla is a physician based in the Philippines.<\/p>\n<p>Dr. Mark Jason D.C. Milan is a pediatrician based in the Philippines.<\/p>\n<p>Dr. Camille K. Pascasio is an internist based in the Philippines.<\/p>\n<p>Dr. Lorenz Fort E. Revillas is a medical oncology fellow based in the Philippines.<\/p>\n<p>Dr. Denise Joy C. Lopez is an endocrinology fellow based in the Philippines.<\/p>\n<p>Dr. Nikolas Leandro R. Daguno is pediatrician based in the Philippines.<\/p>\n<p><strong>Competing interests:<\/strong>\u00a0None<\/p>\n<p><strong>Handling Editor:<\/strong> Neha Faruqui<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2018&#8217;Prevention is better than cure\u201d \u2013 this adage has been around for centuries, and remains to be a fundamental principle of modern medicine. As we celebrate world cancer prevention awareness month this February, we focus on cervical cancer, which has become one of the most preventable malignancies, thanks to effective primary and secondary prevention strategies. [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":402,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[277],"tags":[412],"class_list":["post-39979","post","type-post","status-publish","format-standard","hentry","category-cancer-care","tag-cervical-cancer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog<\/title>\n<meta name=\"description\" content=\"This blog discusses the barriers to cervical cancer prevention in the Philippines.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog\" \/>\n<meta property=\"og:description\" content=\"This blog discusses the barriers to cervical cancer prevention in the Philippines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Global Health blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-25T10:54:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-25T10:55:33+00:00\" \/>\n<meta name=\"author\" content=\"BMJ GH Blogs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ GH Blogs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/\"},\"author\":{\"name\":\"BMJ GH Blogs\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/person\\\/50ae4519b6b7a0e745ddeef52a34fd4e\"},\"headline\":\"Addressing barriers to cervical cancer prevention in the Philippines\",\"datePublished\":\"2024-02-25T10:54:16+00:00\",\"dateModified\":\"2024-02-25T10:55:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/\"},\"wordCount\":904,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\"},\"keywords\":[\"cervical cancer\"],\"articleSection\":[\"Cancer care\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/\",\"name\":\"Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#website\"},\"datePublished\":\"2024-02-25T10:54:16+00:00\",\"dateModified\":\"2024-02-25T10:55:33+00:00\",\"description\":\"This blog discusses the barriers to cervical cancer prevention in the Philippines.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2024\\\/02\\\/25\\\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Addressing barriers to cervical cancer prevention in the Philippines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\",\"name\":\"BMJ Global Health blog\",\"description\":\"Comment, discussion and debate on all aspects of global health across BMJ\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\",\"name\":\"BMJ Global Health blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2017\\\/11\\\/blog-logo-gh.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2017\\\/11\\\/blog-logo-gh.png\",\"width\":275,\"height\":34,\"caption\":\"BMJ Global Health blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/person\\\/50ae4519b6b7a0e745ddeef52a34fd4e\",\"name\":\"BMJ GH Blogs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g\",\"caption\":\"BMJ GH Blogs\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/author\\\/nfaruqui\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog","description":"This blog discusses the barriers to cervical cancer prevention in the Philippines.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/","og_locale":"en_US","og_type":"article","og_title":"Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog","og_description":"This blog discusses the barriers to cervical cancer prevention in the Philippines.","og_url":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/","og_site_name":"BMJ Global Health blog","article_published_time":"2024-02-25T10:54:16+00:00","article_modified_time":"2024-02-25T10:55:33+00:00","author":"BMJ GH Blogs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BMJ GH Blogs","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/"},"author":{"name":"BMJ GH Blogs","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/person\/50ae4519b6b7a0e745ddeef52a34fd4e"},"headline":"Addressing barriers to cervical cancer prevention in the Philippines","datePublished":"2024-02-25T10:54:16+00:00","dateModified":"2024-02-25T10:55:33+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/"},"wordCount":904,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization"},"keywords":["cervical cancer"],"articleSection":["Cancer care"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/","url":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/","name":"Addressing barriers to cervical cancer prevention in the Philippines - BMJ Global Health blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#website"},"datePublished":"2024-02-25T10:54:16+00:00","dateModified":"2024-02-25T10:55:33+00:00","description":"This blog discusses the barriers to cervical cancer prevention in the Philippines.","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2024\/02\/25\/addressing-barriers-to-cervical-cancer-prevention-in-the-philippines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmjgh\/"},{"@type":"ListItem","position":2,"name":"Addressing barriers to cervical cancer prevention in the Philippines"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#website","url":"https:\/\/blogs.bmj.com\/bmjgh\/","name":"BMJ Global Health blog","description":"Comment, discussion and debate on all aspects of global health across BMJ","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmjgh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization","name":"BMJ Global Health blog","url":"https:\/\/blogs.bmj.com\/bmjgh\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2017\/11\/blog-logo-gh.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2017\/11\/blog-logo-gh.png","width":275,"height":34,"caption":"BMJ Global Health blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/person\/50ae4519b6b7a0e745ddeef52a34fd4e","name":"BMJ GH Blogs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/14562bbc571adff51aba3940bf12dd1c4584b4420d3e9a4a5ccd321120d705b9?s=96&d=mm&r=g","caption":"BMJ GH Blogs"},"url":"https:\/\/blogs.bmj.com\/bmjgh\/author\/nfaruqui\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts\/39979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/users\/402"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/comments?post=39979"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts\/39979\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/media?parent=39979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/categories?post=39979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/tags?post=39979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}